Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950149-06-000545
Filing Date
2006-11-15
Accepted
2006-11-15 14:18:25
Documents
3
Effectiveness Date
2006-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f25243e8vk.htm DEFA14A 10676
2 EXHIBIT 99.1 f25243exv99w1.htm EX-99.1 36162
3 GRAPHIC f25243f2524301.gif GRAPHIC 2796
  Complete submission text file 0000950149-06-000545.txt   52379
Mailing Address 185 BERRY STREET SUITE 6504 SAN FRANCISCO CA 94107
Business Address 185 BERRY STREET SUITE 6504 SAN FRANCISCO CA 94107 4155127624
SIRNA THERAPEUTICS INC (Filer) CIK: 0000892112 (see all company filings)

EIN.: 341697351 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-27914 | Film No.: 061219343
SIC: 2834 Pharmaceutical Preparations